Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.

Lee SH, Son MH, Sung KW, Choi YB, Lee NH, Yoo KH, Koo HH, Lim do H, Shin HJ.

J Neurooncol. 2014 Dec;120(3):507-13. doi: 10.1007/s11060-014-1576-1. Epub 2014 Aug 10.

PMID:
25108776
[PubMed - in process]
2.

Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.

Sung KW, Son MH, Lee SH, Yoo KH, Koo HH, Kim JY, Cho EJ, Lee SK, Choi YS, Lim DH, Kim JS, Kim DW.

Bone Marrow Transplant. 2013 Jan;48(1):68-73. doi: 10.1038/bmt.2012.86. Epub 2012 May 28.

PMID:
22635247
[PubMed - indexed for MEDLINE]
3.

Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.

Sung KW, Lim do H, Son MH, Lee SH, Yoo KH, Koo HH, Kim JH, Suh YL, Joung YS, Shin HJ.

Neuro Oncol. 2013 Mar;15(3):352-9. doi: 10.1093/neuonc/nos304. Epub 2012 Dec 20.

PMID:
23258845
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Tandem high-dose chemotherapy and auto-SCT for malignant brain tumors in children under 3 years of age.

Sung KW, Lim DH, Lee SH, Yoo KH, Koo HH, Kim JH, Suh YL, Joung YS, Shin HJ.

Bone Marrow Transplant. 2013 Jul;48(7):932-8. doi: 10.1038/bmt.2012.263. Epub 2013 Jan 14.

PMID:
23318534
[PubMed - indexed for MEDLINE]
5.

Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.

Baek HJ, Park HJ, Sung KW, Lee SH, Han JW, Koh KN, Im HJ, Kang HJ, Park KD.

J Neurooncol. 2013 Sep;114(3):329-38. doi: 10.1007/s11060-013-1188-1. Epub 2013 Jul 4.

PMID:
23824533
[PubMed - indexed for MEDLINE]
6.

Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.

Park ES, Sung KW, Baek HJ, Park KD, Park HJ, Won SC, Lim do H, Kim HS.

J Korean Med Sci. 2012 Feb;27(2):135-40. doi: 10.3346/jkms.2012.27.2.135. Epub 2012 Jan 27.

PMID:
22323859
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].

Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U.

Klin Padiatr. 1998 Jul-Aug;210(4):248-55. German.

PMID:
9743961
[PubMed - indexed for MEDLINE]
8.

Hematologic recovery after tandem high-dose chemotherapy and autologous stem cell transplantation in children with high-risk solid tumors.

Son MH, Kim DH, Lee SH, Yoo KH, Sung KW, Koo HH, Kim JY, Cho EJ, Kang ES, Kim DW.

J Korean Med Sci. 2013 Feb;28(2):220-6. doi: 10.3346/jkms.2013.28.2.220. Epub 2013 Jan 29.

PMID:
23400387
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors.

Chueh HW, Sung KW, Lee SH, Yoo KH, Koo HH, Kim JY, Cho EJ.

Pediatr Blood Cancer. 2012 Mar;58(3):441-7. doi: 10.1002/pbc.23198. Epub 2011 Jun 2.

PMID:
21638755
[PubMed - indexed for MEDLINE]
10.

Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.

Zia MI, Forsyth P, Chaudhry A, Russell J, Stewart DA.

Bone Marrow Transplant. 2002 Nov;30(9):565-9.

PMID:
12407430
[PubMed - indexed for MEDLINE]
Free Article
11.

[Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].

Imataki O, Aoyama T, Tamai Y, Kawakami K.

Gan To Kagaku Ryoho. 2007 Oct;34(10):1633-6. Japanese.

PMID:
17940379
[PubMed - indexed for MEDLINE]
12.

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.

Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB.

Biol Blood Marrow Transplant. 1999;5(5):306-15.

PMID:
10534061
[PubMed - indexed for MEDLINE]
13.

High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.

Lewin J, Dickinson M, Voskoboynik M, Collins M, Ritchie D, Toner G.

Intern Med J. 2014 Aug;44(8):771-8. doi: 10.1111/imj.12486.

PMID:
24893627
[PubMed - in process]
14.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
[PubMed - indexed for MEDLINE]
15.

High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.

Sung KW, Yoo KH, Cho EJ, Koo HH, Lim do H, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT.

Pediatr Blood Cancer. 2007 Apr;48(4):408-15.

PMID:
17066462
[PubMed - indexed for MEDLINE]
16.

Results of autologous stem cell transplant in multiple myeloma patients with renal failure.

Badros A, Barlogie B, Siegel E, Roberts J, Langmaid C, Zangari M, Desikan R, Shaver MJ, Fassas A, McConnell S, Muwalla F, Barri Y, Anaissie E, Munshi N, Tricot G.

Br J Haematol. 2001 Sep;114(4):822-9.

PMID:
11564069
[PubMed - indexed for MEDLINE]
17.

Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation.

Iguchi A, Kobayashi R, Kaneda M, Kobayashi K.

Pediatr Blood Cancer. 2010 Mar;54(3):437-43. doi: 10.1002/pbc.22314.

PMID:
19911420
[PubMed - indexed for MEDLINE]
18.

Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.

Ozkaynak MF, Matthay K, Cairo M, Harris RE, Feig S, Reynolds CP, Buckley J, Villablanca JG, Seeger RC.

J Clin Oncol. 1998 Mar;16(3):937-44.

PMID:
9508176
[PubMed - indexed for MEDLINE]
19.

High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB).

Benesch M, Bartelheim K, Fleischhack G, Gruhn B, Schlegel PG, Witt O, Stachel KD, Hauch H, Urban C, Quehenberger F, Massimino M, Pietsch T, Hasselblatt M, Giangaspero F, Kordes U, Schneppenheim R, Hauser P, Klingebiel T, Frühwald MC.

Bone Marrow Transplant. 2014 Mar;49(3):370-5. doi: 10.1038/bmt.2013.208. Epub 2014 Jan 13.

PMID:
24419520
[PubMed - in process]
20.

Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.

Kameoka Y, Takahashi N, Ishizawa K, Kato Y, Ito J, Sasaki O, Murai K, Noji H, Hirokawa M, Tajima K, Shichishima T, Ishida Y, Harigae H, Sawada K.

Int J Hematol. 2012 Nov;96(5):624-30. doi: 10.1007/s12185-012-1186-7. Epub 2012 Oct 1.

PMID:
23054649
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk